Form 8-K - Current report:
SEC Accession No. 0001193125-24-175915
Filing Date
2024-07-08
Accepted
2024-07-08 07:40:53
Documents
13
Period of Report
2024-07-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d574834d8k.htm   iXBRL 8-K 28272
  Complete submission text file 0001193125-24-175915.txt   151736

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hlvx-20240708.xsd EX-101.SCH 2840
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hlvx-20240708_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hlvx-20240708_pre.xml EX-101.PRE 11251
15 EXTRACTED XBRL INSTANCE DOCUMENT d574834d8k_htm.xml XML 3621
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41365 | Film No.: 241103372
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)